NACE 28.92 in FR. Official registry identity, filed financial evidence and a rounded indicative valuation range on one indexed company profile.
Historical rounded range based on the latest available public filing for fiscal year 2020. This is not a current market value or asking price.
Based on filed company accountsCreate a free account to see the detailed curve, the factors that influence it, and an indicative five-year outlook.
Free account · private workspace
You have seen the historical curve. Create a free account to explore a private five-year value scenario and the assumptions behind it.
The historical indicative range for EMULBITUME uses the latest available public filing and sector calibration. It is not a current market value or asking price; current owner or advisor data is needed for a full valuation.
This company is not currently listed for sale on Upswitch.
This is an estimate, not an asking price. It is based on dated public sources and is not an owner forecast, offer, investment advice, or confirmation that the company is for sale.
Request verified control to add current figures, improve the profile and manage what happens next. We verify ownership before granting access.
EMULBITUME is a business in NACE sector 28.92 based in France. The company was founded in 2003, incorporated as a 5710.
EMULBITUME is listed in French National Business Register (RNE/INPI) under registry number 445283732. This profile consolidates official annual accounts into one indexable company dossier.
Within the French NACE 28.92 cluster, public-record data is filed annually via the national company registry.
Across the 2016-2020 window revenue has declined, moving from €3,395,400 to €1,695,599.
The most recent annual filing covers 2020 (period end 2020-12-31).
If you are researching EMULBITUME for acquisition, investment, or due-diligence purposes, this page consolidates its firmographics, multi-year filings, and a historical indicative range based on the latest available public filing, not a current market value.
Public regulator-filed figures across 5 years.
Fiscal year | Revenue | EBITDA | Total assets | Equity | Filing |
|---|---|---|---|---|---|
| 202031 Dec 2020 | €1,695,599 | - | €1,696,499 | €431,727 | - |
| 201931 Dec 2019 | €2,093,038 | - | €1,668,702 | €457,444 | - |
| 201831 Dec 2018 | €1,640,059 | - | €1,757,776 | €392,345 | - |
| 201730 Sept 2017 | €2,665,603 | - | €2,333,285 | €761,552 | - |
| 201630 Sept 2016 | €3,395,400 | - | €3,125,132 | €756,360 | - |
EMULBITUME was founded in 2003 and is registered with French National Business Register (RNE/INPI), incorporated as a 5710.
EMULBITUME is registered under NACE 28.92: NACE 28.92. That places the business within the French cluster for this activity.
The most recently filed annual accounts cover fiscal year 2020 (period end 2020-12-31), publicly available via French National Business Register (RNE/INPI).
This page shows a rounded historical indicative range for EMULBITUME, based on the latest available public filing for fiscal year 2020. It is not a current market value, asking price, certified or statutory valuation, or financial, investment, tax or legal advice. Verify current figures before relying on it for any decision or transaction.
Company identity and public facts are reused from the official or licensed source named on this page, with its filing or update date. Upswitch estimates remain distinct from source facts and do not imply endorsement by the registry. Natural-person enterprises are excluded from public valuation pages, and public registry personal data is not used for direct marketing.
Connected to this company and want something corrected? Request a correction or removal · Privacy policy · Terms & conditions · Data sources & evidence
